$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Gut microbiota and liver diseases 원문보기

World journal of gastroenterology : WJG, v.21 no.6, 2015년, pp.1691 -   

Minemura, Masami

Abstract AI-Helper 아이콘AI-Helper

Several studies revealed that gut microbiota are associated with various human diseases, e.g., metabolic diseases, allergies, gastroenterological diseases, and liver diseases. The liver can be greatly affected by changes in gut microbiota due to the entry of gut bacteria or their metabolites into th...

참고문헌 (108)

  1. Orrhage K, Nord CE. Bifidobacteria and lactobacilli in human health. Drugs Exp Clin Res 2000;26:95-111. 

  2. 10.1097/MCG.0000000000000229 Patrignani P, Tacconelli S, Bruno A. Gut microbiota, host gene expression, and aging. J Clin Gastroenterol 2014;48 Suppl 1:S28-S31. 

  3. Voreades, Noah, Kozil, Anne, Weir, Tiffany L.. Diet and the development of the human intestinal microbiome. Frontiers in microbiology, vol.5, 494-.

  4. 10.1513/AnnalsATS.201306-161MG Neish AS. Mucosal immunity and the microbiome. Ann Am Thorac Soc 2014;11 Suppl 1:S28-S32. 

  5. Chung, H., Pamp, Sunje J., Hill, Jonathan A., Surana, Neeraj K., Edelman, Sanna M., Troy, Erin B., Reading, Nicola C., Villablanca, Eduardo J., Wang, S., Mora, Jorge R., Umesaki, Y., Mathis, D., Benoist, C., Relman, David A., Kasper, Dennis L.. Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota. Cell, vol.149, no.7, 1578-1593.

  6. Kamada, Nobuhiko, Seo, Sang-Uk, Chen, Grace Y., Núñez, Gabriel. Role of the gut microbiota in immunity and inflammatory disease. Nature reviews. Immunology, vol.13, no.5, 321-335.

  7. Spasova, Darina S., Surh, Charles D.. Blowing on Embers: Commensal Microbiota and Our Immune System. Frontiers in immunology, vol.5, 318-.

  8. Quigley, Eamonn M, Monsour, Howard P. The gut microbiota and the liver: implications for clinical practice. Expert review of gastroenterology & hepatology, vol.7, no.8, 723-732.

  9. Chassaing, Benoit, Etienne‐Mesmin, Lucie, Gewirtz, Andrew T.. Microbiota‐liver axis in hepatic disease. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.59, no.1, 328-339.

  10. Goel, Amit, Gupta, Mahesh, Aggarwal, Rakesh. Gut microbiota and liver disease. Journal of gastroenterology and hepatology, vol.29, no.6, 1139-1148.

  11. Visschers, Ruben G.J., Luyer, Misha D., Schaap, Frank G., Olde Damink, Steven W.M., Soeters, Peter B.. The gut-liver axis :. Current opinion in clinical nutrition and metabolic care, vol.16, no.5, 576-581.

  12. Schnabl, B., Brenner, D.A.. Interactions Between the Intestinal Microbiome and Liver Diseases. Gastroenterology, vol.146, no.6, 1513-1524.

  13. 10.1016/j.biopsych.2014.07.012 Bruce-Keller AJ, Salbaum JM, Luo M, Blanchard E 4th, Taylor CM, Welsh DA, Berthoud HR. Obese-type Gut Microbiota Induce Neurobehavioral Changes in the Absence of Obesity. Biol Psychiatry 2014;Epub ahead of print. 

  14. Hyland NP, Quigley EM, Brint E. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions. World J Gastroenterol 2014;20:8859-8866. 

  15. 10.1016/j.bbr.2014.07.027 O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 2015;277:32-48. 

  16. Lagier, Jean-Christophe, Million, Matthieu, Hugon, Perrine, Armougom, Fabrice, Raoult, Didier. Human Gut Microbiota: Repertoire and Variations. Frontiers in cellular and infection microbiology, vol.2, 136-.

  17. Biagi, Elena, Candela, Marco, Fairweather-Tait, Susan, Franceschi, Claudio, Brigidi, Patrizia. Ageing of the human metaorganism: the microbial counterpart. Age, vol.34, no.1, 247-267.

  18. Petrosino, Joseph F, Highlander, Sarah, Luna, Ruth Ann, Gibbs, Richard A, Versalovic, James. Metagenomic Pyrosequencing and Microbial Identification. Clinical chemistry, vol.55, no.5, 856-866.

  19. 10.1073/pnas.1000097107 Claesson MJ, Cusack S, O’Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, Marchesi JR, Falush D, Dinan T, Fitzgerald G. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011;108 Suppl 1:4586-4591. 

  20. 10.1099/0022-1317-51-5-448 Hopkins MJ, Macfarlane GT. Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J Med Microbiol 2002;51:448-454. 

  21. Woodmansey, E.J.. Intestinal bacteria and ageing. Journal of applied microbiology, vol.102, no.5, 1178-1186.

  22. Woodmansey, Emma J., McMurdo, Marion E. T., Macfarlane, George T., Macfarlane, Sandra. Comparison of Compositions and Metabolic Activities of Fecal Microbiotas in Young Adults and in Antibiotic-Treated and Non-Antibiotic-Treated Elderly Subjects. Applied and environmental microbiology, vol.70, no.10, 6113-6122.

  23. 10.1152/physrev.1990.70.2.567 Bergman EN. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev 1990;70:567-590. 

  24. 10.1155/2014/162021 Puddu A, Sanguineti R, Montecucco F, Viviani GL. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators Inflamm 2014;2014:162021. 

  25. 10.1152/physrev.2001.81.3.1031 Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001;81:1031-1064. 

  26. Maslowski, Kendle M., Vieira, Angelica T., Ng, Aylwin, Kranich, Jan, Sierro, Frederic, Di Yu,, Schilter, Heidi C., Rolph, Michael S., Mackay, Fabienne, Artis, David, Xavier, Ramnik J., Teixeira, Mauro M., Mackay, Charles R.. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, vol.461, no.7268, 1282-1286.

  27. Sina, Christian, Gavrilova, Olga, Förster, Matti, Till, Andreas, Derer, Stefanie, Hildebrand, Friederike, Raabe, Björn, Chalaris, Athena, Scheller, Jürgen, Rehmann, Ateequr, Franke, Andre, Ott, Stephan, Häsler, Robert, Nikolaus, Susanna, Fölsch, Ulrich R., Rose-John, Stefan, Jiang, Hui-Ping, Li, Jun, Schreiber, Stefan, Rosenstiel, Philip. G Protein-Coupled Receptor 43 Is Essential for Neutrophil Recruitment during Intestinal Inflammation. The journal of immunology : official journal of the American Association of Immunologists, vol.183, no.11, 7514-7522.

  28. Clemente, Jose C., Ursell, Luke K., Parfrey, L., Knight, R.. The Impact of the Gut Microbiota on Human Health: An Integrative View. Cell, vol.148, no.6, 1258-1270.

  29. Round, June L., Mazmanian, Sarkis K.. Inducible Foxp3 + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences of the United States of America, vol.107, no.27, 12204-12209.

  30. Atarashi, Koji, Tanoue, Takeshi, Shima, Tatsuichiro, Imaoka, Akemi, Kuwahara, Tomomi, Momose, Yoshika, Cheng, Genhong, Yamasaki, Sho, Saito, Takashi, Ohba, Yusuke, Taniguchi, Tadatsugu, Takeda, Kiyoshi, Hori, Shohei, Ivanov, Ivaylo I., Umesaki, Yoshinori, Itoh, Kikuji, Honda, Kenya. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species. Science, vol.331, no.6015, 337-341.

  31. 10.1016/j.febslet.2014.06.042 Zeissig S, Blumberg RS. Commensal microbial regulation of natural killer T cells at the frontiers of the mucosal immune system. FEBS Lett 2014;588:4188-4194. 

  32. Olszak, Torsten, Neves, Joana F., Dowds, C. Marie, Baker, Kristi, Glickman, Jonathan, Davidson, Nicholas O., Lin, Chyuan-Sheng, Jobin, Christian, Brand, Stephan, Sotlar, Karl, Wada, Koichiro, Katayama, Kazufumi, Nakajima, Atsushi, Mizuguchi, Hiroyuki, Kawasaki, Kunito, Nagata, Kazuhiro, Müller, Werner, Snapper, Scott B., Schreiber, Stefan, Kaser, Arthur, Zeissig, Sebastian, Blumberg, Richard S.. Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature, vol.509, no.7501, 497-502.

  33. 10.1155/2014/689492 Ferreira CM, Vieira AT, Vinolo MA, Oliveira FA, Curi R, Martins Fdos S. The central role of the gut microbiota in chronic inflammatory diseases. J Immunol Res 2014;2014:689492. 

  34. Hansen, Camilla Hartmann Friis, Nielsen, Dennis Sandris, Kverka, Miloslav, Zakostelska, Zuzana, Klimesova, Klara, Hudcovic, Tomas, Tlaskalova-Hogenova, Helena, Hansen, Axel Kornerup. Patterns of Early Gut Colonization Shape Future Immune Responses of the Host. PloS one, vol.7, no.3, e34043-.

  35. Ivanov, Ivaylo I., Honda, K.. Intestinal Commensal Microbes as Immune Modulators. Cell host & microbe, vol.12, no.4, 496-508.

  36. Seo, Yeon Seok, Shah, Vijay H.. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clinical and molecular hepatology, vol.18, no.4, 337-346.

  37. Quigley, E.M.M., Stanton, C., Murphy, E.F.. The gut microbiota and the liver. Pathophysiological and clinical implications. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.58, no.5, 1020-1027.

  38. Clarke, Siobhan F., Murphy, Eileen F., Nilaweera, Kanishka, Ross, Paul R., Shanahan, Fergus, O’Toole, Paul W., Cotter, Paul D.. The gut microbiota and its relationship to diet and obesity : New insights. Gut microbes, vol.3, no.3, 186-202.

  39. 10.1038/nature10809 Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012;482:179-185. 

  40. Zhu, Lixin, Baker, Susan S., Gill, Chelsea, Liu, Wensheng, Alkhouri, Razan, Baker, Robert D., Gill, Steven R.. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.57, no.2, 601-609.

  41. Imajo, Kento, Fujita, Koji, Yoneda, Masato, Nozaki, Yuichi, Ogawa, Yuji, Shinohara, Yoshiyasu, Kato, Shingo, Mawatari, Hironori, Shibata, Wataru, Kitani, Hiroshi, Ikejima, Kenichi, Kirikoshi, Hiroyuki, Nakajima, Noriko, Saito, Satoru, Maeyama, Shiro, Watanabe, Sumio, Wada, Koichiro, Nakajima, Atsushi. Hyperresponsivity to Low-Dose Endotoxin during Progression to Nonalcoholic Steatohepatitis Is Regulated by Leptin-Mediated Signaling. Cell metabolism, vol.16, no.1, 44-54.

  42. Miettinen, T. A.. Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease. Gut: journal of the British Society of Gastroenterology, vol.13, no.9, 682-689.

  43. Sung, J. Y., Shaffer, E. A., Costerton, J. W.. Antibacterial activity of bile salts against common biliary pathogens : Effects of hydrophobicity of the molecule and in the presence of phospholipids. Digestive diseases and sciences, vol.38, no.11, 2104-2112.

  44. Gunnarsdottir, Steingerdur Anna, Sadik, Riadh, Shev, Steven, Simrén, Magnus, Sjövall, Henrik, Stotzer, Per-Ove, Abrahamsson, Hasse, Olsson, Rolf, Björnsson, Einar S. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.98, no.6, 1362-1370.

  45. Chen, Yanfei, Yang, Fengling, Lu, Haifeng, Wang, Baohong, Chen, Yunbo, Lei, Dajiang, Wang, Yuezhu, Zhu, Baoli, Li, Lanjuan. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.54, no.2, 562-572.

  46. Lu, Haifeng, Wu, Zhongwen, Xu, Wei, Yang, Jiezuan, Chen, Yunbo, Li, Lanjuan. Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection : Intestinal Microbiota of HBV Cirrhotic Patients. Microbial ecology, vol.61, no.3, 693-703.

  47. Qin, Nan, Yang, Fengling, Li, Ang, Prifti, Edi, Chen, Yanfei, Shao, Li, Guo, Jing, Le Chatelier, Emmanuelle, Yao, Jian, Wu, Lingjiao, Zhou, Jiawei, Ni, Shujun, Liu, Lin, Pons, Nicolas, Batto, Jean Michel, Kennedy, Sean P., Leonard, Pierre, Yuan, Chunhui, Ding, Wenchao, Chen, Yuanting, Hu, Xinjun, Zheng, Beiwen, Qian, Guirong, Xu, Wei, Ehrlich, S. Dusko, Zheng, Shusen, Li, Lanjuan. Alterations of the human gut microbiome in liver cirrhosis. Nature, vol.513, no.7516, 59-64.

  48. Yan, Arthur W., E. Fouts, Derrick, Brandl, Johannes, Stärkel, Peter, Torralba, Manolito, Schott, Eckart, Tsukamoto, Hide, E. Nelson, Karen, A. Brenner, David, Schnabl, Bernd. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.53, no.1, 96-105.

  49. Mutlu, Ece A., Gillevet, Patrick M., Rangwala, Huzefa, Sikaroodi, Masoumeh, Naqvi, Ammar, Engen, Phillip A., Kwasny, Mary, Lau, Cynthia K., Keshavarzian, Ali. Colonic microbiome is altered in alcoholism. American journal of physiology, Gastrointestinal and liver physiology, vol.302, no.9, G966-G978.

  50. Fukui, H., Brauner, B., Bode, J.Ch., Bode, Ch.. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.12, no.2, 162-169.

  51. 10.1152/ajpgi.1998.275.6.G1252 Rivera CA, Bradford BU, Seabra V, Thurman RG. Role of endotoxin in the hypermetabolic state after acute ethanol exposure. Am J Physiol 1998;275:G1252-G1258. 

  52. 10.1111/jgh.12019 Roh YS, Seki E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol 2013;28 Suppl 1:38-42. 

  53. Tuomisto, Sari, Pessi, Tanja, Collin, Pekka, Vuento, Risto, Aittoniemi, Janne, Karhunen, Pekka J. Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics. BMC gastroenterology, vol.14, 40-40.

  54. Bajaj, Jasmohan S., Ridlon, Jason M., Hylemon, Phillip B., Thacker, Leroy R., Heuman, Douglas M., Smith, Sean, Sikaroodi, Masoumeh, Gillevet, Patrick M.. Linkage of gut microbiome with cognition in hepatic encephalopathy. American journal of physiology, Gastrointestinal and liver physiology, vol.302, no.1, G168-G175.

  55. Bajaj, Jasmohan S., Hylemon, Phillip B., Ridlon, Jason M., Heuman, Douglas M., Daita, Kalyani, White, Melanie B., Monteith, Pamela, Noble, Nicole A., Sikaroodi, Masoumeh, Gillevet, Patrick M.. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. American journal of physiology, Gastrointestinal and liver physiology, vol.303, no.6, G675-G685.

  56. Yoshimoto, Shin, Loo, Tze Mun, Atarashi, Koji, Kanda, Hiroaki, Sato, Seidai, Oyadomari, Seiichi, Iwakura, Yoichiro, Oshima, Kenshiro, Morita, Hidetoshi, Hattori, Masahisa, Honda, Kenya, Ishikawa, Yuichi, Hara, Eiji, Ohtani, Naoko. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature, vol.499, no.7456, 97-101.

  57. Dapito, Dianne H., Mencin, A., Gwak, G.Y., Pradere, J.P., Jang, M.K., Mederacke, I., Caviglia, Jorge M., Khiabanian, H., Adeyemi, A., Bataller, R., Lefkowitch, Jay H., Bower, M., Friedman, R., Sartor, R., Rabadan, R., Schwabe, Robert F.. Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4. Cancer cell, vol.21, no.4, 504-516.

  58. Bindels, L B, Porporato, P, Dewulf, E M, Verrax, J, Neyrinck, A M, Martin, J C, Scott, K P, Buc Calderon, P, Feron, O, Muccioli, G G, Sonveaux, P, Cani, P D, Delzenne, N M. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. The British journal of cancer, vol.107, no.8, 1337-1344.

  59. Zhang, J.P., Yan, J., Xu, J., Pang, X.H., Chen, M.S., Li, L., Wu, C., Li, S.P., Zheng, L.. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.50, no.5, 980-989.

  60. Numasaki, Muneo, Fukushi, Jun-ichi, Ono, Mayumi, Narula, Satwant K, Zavodny, Paul J, Kudo, Toshio, Robbins, Paul D, Tahara, Hideaki, Lotze, Michael T. Interleukin-17 promotes angiogenesis and tumor growth.. Blood, vol.101, no.7, 2620-2627.

  61. Ivanov, Ivaylo I., Atarashi, Koji, Manel, Nicolas, Brodie, Eoin L., Shima, Tatsuichiro, Karaoz, Ulas, Wei, Dongguang, Goldfarb, Katherine C., Santee, Clark A., Lynch, Susan V., Tanoue, Takeshi, Imaoka, Akemi, Itoh, Kikuji, Takeda, Kiyoshi, Umesaki, Yoshinori, Honda, Kenya, Littman, Dan R.. Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria. Cell, vol.139, no.3, 485-498.

  62. Ersöz, Galip, Aydin, Ahmet, Erdem, Serdar, Yüksel, Didem, Akarca, Ulus, Kumanlioglu, Kamil. Intestinal permeability in liver cirrhosis :. European journal of gastroenterology & hepatology, vol.11, no.4, 409-412.

  63. Khungar, Vandana, Poordad, Fred. Hepatic Encephalopathy. Clinics in liver disease, vol.16, no.2, 301-320.

  64. Haussinger, D, Schliess, F. Pathogenetic mechanisms of hepatic encephalopathy. Gut: journal of the British Society of Gastroenterology, vol.57, no.8, 1156-1165.

  65. Koulaouzidis, Anastasios, Bhat, Shivaram, Saeed, Athar A. Spontaneous bacterial peritonitis. World journal of gastroenterology : WJG, vol.15, no.9, 1042-.

  66. Lata, Jan, Stiburek, Oldřich, Kopacova, Marcela. Spontaneous bacterial peritonitis: A severe complication ofliver cirrhosis. World journal of gastroenterology : WJG, vol.15, no.44, 5505-.

  67. Medina, Jesús, Fernández-Salazar, Luis I., García-Buey, Luisa, Moreno-Otero, Ricardo. Approach to the Pathogenesis and Treatment of Nonalcoholic Steatohepatitis. Diabetes care, vol.27, no.8, 2057-2066.

  68. Loguercio, Carmela, Federico, Alessandro, Tuccillo, Concetta, Terracciano, Fulvia, D’Auria, Mauro Valeriano, De Simone, Claudio, Blanco, Camillo Del Vecchio. Beneficial Effects of a Probiotic VSL#3 on Parameters of Liver Dysfunction in Chronic Liver Diseases. Journal of clinical gastroenterology, vol.39, no.6, 540-543.

  69. 10.1177/030006058701500602 Loguercio C, Del Vecchio Blanco C, Coltorti M. Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study. J Int Med Res 1987;15:335-343. 

  70. Loguercio, C., Abbiati, R., Rinaldi, M., Romano, A., Del Vecchio Blanco, C., Coltorti, M.. Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.23, no.1, 39-46.

  71. Liu, Qing, Duan, Zhong Ping, Ha, Da Kang, Bengmark, Stig, Kurtovic, Jelica, Riordan, Stephen M.. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.39, no.5, 1441-1449.

  72. Malaguarnera, Mariano, Greco, Filippo, Barone, Gloria, Gargante, Maria Pia, Malaguarnera, Michele, Toscano, Maria Antonietta. Bifidobacterium longum with Fructo-Oligosaccharide (FOS) Treatment in Minimal Hepatic Encephalopathy: A Randomized, Double-Blind, Placebo-Controlled Study. Digestive diseases and sciences, vol.52, no.11, 3259-3265.

  73. Bajaj, Jasmohan S., Saeian, Kia, Christensen, Kenneth M., Hafeezullah, Muhammad, Varma, Rajiv R., Franco, Jose, Pleuss, Joan A., Krakower, Glenn, Hoffmann, Raymond G., Binion, David G.. Probiotic Yogurt for the Treatment of Minimal Hepatic Encephalopathy. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.103, no.7, 1707-1715.

  74. Sharma, Praveen, Sharma, Barjesh C., Puri, Vinod, Sarin, Shiv Kumar. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. European journal of gastroenterology & hepatology, vol.20, no.6, 506-511.

  75. Mittal, Vibhu Vibhas, Sharma, Barjesh Chander, Sharma, Praveen, Sarin, Shiv Kumar. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. European journal of gastroenterology & hepatology, vol.23, no.8, 725-732.

  76. Malaguarnera, Mariano, Gargante, Maria Pia, Malaguarnera, Giulia, Salmeri, Mario, Mastrojeni, Silvana, Rampello, Liborio, Pennisi, Giovanni, Volti, Giovanni Li, Galvano, Fabio. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. European journal of gastroenterology & hepatology, vol.22, no.2, 199-206.

  77. Pereg, D., Kotliroff, A., Gadoth, N., Hadary, R., Lishner, M., Kitay-Cohen, Y.. Probiotics for patients with compensated liver cirrhosis: A double-blind placebo-controlled study. Nutrition, vol.27, no.2, 177-181.

  78. 10.1002/14651858.CD008716.pub2 McGee RG, Bakens A, Wiley K, Riordan SM, Webster AC. Probiotics for patients with hepatic encephalopathy. Cochrane Database Syst Rev 2011;CD008716. 

  79. Holte, Kathrine, Krag, Aleksander, Gluud, Lise Lotte. Systematic review and meta‐analysis of randomized trials on probiotics for hepatic encephalopathy. Hepatology research : the official journal of the Japan Society of Hepatology, vol.42, no.10, 1008-1015.

  80. Agrawal, Amit, Sharma, Barjesh Chander, Sharma, Praveen, Sarin, Shiv Kumar. Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis: An Open-Label, Randomized Controlled Trial of Lactulose, Probiotics, and No Therapy. The American journal of gastroenterology : official publication of the National Gastroenterological Association, vol.107, no.7, 1043-1050.

  81. 10.1016/j.cgh.2013.11.006 Lunia MK, Sharma BC, Sharma P, Sachdeva S, Srivastava S. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial. Clin Gastroenterol Hepatol 2014;12:1003-8.e1. 

  82. Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., Puri, P., Sterling, R. K., Luketic, V., Stravitz, R. T., Siddiqui, M. S., Fuchs, M., Thacker, L. R., Wade, J. B., Daita, K., Sistrun, S., White, M. B., Noble, N. A., Thorpe, C., Kakiyama, G., Pandak, W. M., Sikaroodi, M., Gillevet, P. M.. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Alimentary pharmacology & therapeutics, vol.39, no.10, 1113-1125.

  83. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438. 

  84. Neuschwander-Tetri, Brent A., Caldwell, Stephen H.. Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.37, no.5, 1202-1219.

  85. Miele, Luca, Valenza, Venanzio, La Torre, Giuseppe, Montalto, Massimo, Cammarota, Giovanni, Ricci, Riccardo, Mascianà, Roberta, Forgione, Alessandra, Gabrieli, Maria L., Perotti, Germano, Vecchio, Fabio M., Rapaccini, Gianlodovico, Gasbarrini, Giovanni, Day, Chris P., Grieco, Antonio. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.49, no.6, 1877-1887.

  86. Socha, Piotr, Horvath, Andrea, Vajro, Pietro, Dziechciarz, Piotr, Dhawan, Anil, Szajewska, Hania. Pharmacological Interventions for Nonalcoholic Fatty Liver Disease in Adults and in Children: A Systematic Review. Journal of pediatric gastroenterology and nutrition, vol.48, no.5, 587-596.

  87. Fedorak, Richard N., Madsen, Karen L.. Probiotics and prebiotics in gastrointestinal disorders :. Current opinion in gastroenterology, vol.20, no.2, 146-155.

  88. Li, Zhiping, Yang, Shiqi, Lin, Huizhi, Huang, Jiawen, Watkins, Paul A., Moser, Ann B., DeSimone, Claudio, Song, Xiao-yu, Diehl, Anna Mae. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.37, no.2, 343-350.

  89. Velayudham, Arumugam, Dolganiuc, Angela, Ellis, Michael, Petrasek, Jan, Kodys, Karen, Mandrekar, Pranoti, Szabo, Gyongyi. VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet‐induced nonalcoholic steatohepatitis model in mice. Hepatology : official journal of the American Association for the Study of Liver Diseases, vol.49, no.3, 989-997.

  90. Aller R, De Luis DA, Izaola O, Conde R, Gonzalez Sagrado M, Primo D, De La Fuente B, Gonzalez J. Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial. Eur Rev Med Pharmacol Sci 2011;15:1090-1095. 

  91. Vajro, Pietro, Mandato, Claudia, Licenziati, Maria Rosaria, Franzese, Adriana, Vitale, Dino Franco, Lenta, Selvaggia, Caropreso, Maria, Vallone, Gianfranco, Meli, Rosaria. Effects of Lactobacillus rhamnosus Strain GG in Pediatric Obesity-related Liver Disease. Journal of pediatric gastroenterology and nutrition, vol.52, no.6, 740-743.

  92. Malaguarnera, Michele, Vacante, Marco, Antic, Tijana, Giordano, Maria, Chisari, Giuseppe, Acquaviva, Rosaria, Mastrojeni, Silvana, Malaguarnera, Giulia, Mistretta, Antonio, Li Volti, Giovanni, Galvano, Fabio. Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis. Digestive diseases and sciences, vol.57, no.2, 545-553.

  93. 10.1016/S1665-2681(19)31364-X Wong VW, Won GL, Chim AM, Chu WC, Yeung DK, Li KC, Chan HL. Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study. Ann Hepatol 2013;12:256-262. 

  94. Ma, Yan-Yan, Li, Lin, Yu, Chao-Hui, Shen, Zhe, Chen, Li-Hua, Li, You-Ming. Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.. World journal of gastroenterology : WJG, vol.19, no.40, 6911-6918.

  95. Tannock, Gerald W, Wilson, Charlotte M, Loach, Diane, Cook, Gregory M, Eason, Jocelyn, O'Toole, Paul W, Holtrop, Grietje, Lawley, Blair. Resource partitioning in relation to cohabitation of Lactobacillus species in the mouse forestomach. The ISME journal : multidisciplinary journal of microbial ecology, vol.6, no.5, 927-938.

  96. Gibson, Glenn R., Beatty, Emily R., Wang, Xin, Cummings, John H.. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology, vol.108, no.4, 975-982.

  97. Stadlbauer, V., Mookerjee, R.P., Hodges, S., Wright, G.A.K., Davies, N.A., Jalan, R.. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. Journal of hepatology : the journal of the European Association for the Study of the Liver, vol.48, no.6, 945-951.

  98. Segawa, S., Wakita, Y., Hirata, H., Watari, J.. Oral administration of heat-killed Lactobacillus brevis SBC8803 ameliorates alcoholic liver disease in ethanol-containing diet-fed C57BL/6N mice. International journal of food microbiology, vol.128, no.2, 371-377.

  99. Kirpich, I.A., Solovieva, N.V., Leikhter, S.N., Shidakova, N.A., Lebedeva, O.V., Sidorov, P.I., Bazhukova, T.A., Soloviev, A.G., Barve, S.S., McClain, C.J., Cave, M.. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol, vol.42, no.8, 675-682.

  100. Forsyth, C.B., Farhadi, A., Jakate, S.M., Tang, Y., Shaikh, M., Keshavarzian, A.. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol, vol.43, no.2, 163-172.

  101. 10.1155/2014/715130 Arora S, Kaur IP, Chopra K, Rishi P. Efficiency of double layered microencapsulated probiotic to modulate proinflammatory molecular markers for the management of alcoholic liver disease. Mediators Inflamm 2014;2014:715130. 

  102. Wang, Yuhua, Liu, Yanlong, Sidhu, Anju, Ma, Zhenhua, McClain, Craig, Feng, Wenke. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. American journal of physiology, Gastrointestinal and liver physiology, vol.303, no.1, G32-G41.

  103. Michelotti, Gregory A., Machado, Mariana V., Diehl, Anna Mae. NAFLD, NASH and liver cancer. Nature reviews. Gastroenterology & hepatology, vol.10, no.11, 656-665.

  104. 10.1093/ajcn/83.5.1199 El-Nezami HS, Polychronaki NN, Ma J, Zhu H, Ling W, Salminen EK, Juvonen RO, Salminen SJ, Poussa T, Mykkänen HM. Probiotic supplementation reduces a biomarker for increased risk of liver cancer in young men from Southern China. Am J Clin Nutr 2006;83:1199-1203. 

  105. Kumar, M., Verma, V., Nagpal, R., Kumar, A., Gautam, S.K., Behare, P.V., Grover, C.R., Aggarwal, P.K.. Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB1-induced hepatocellular carcinoma. Gene, vol.490, no.1, 54-59.

  106. Rayes, Nada, Seehofer, Daniel, Theruvath, Tom, Schiller, Reinhold A, Langrehr, Jan M, Jonas, Sven, Bengmark, Stig, Neuhaus, Peter. Supply of Pre- and Probiotics Reduces Bacterial Infection Rates After Liver Transplantation-A Randomized, Double-Blind Trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol.5, no.1, 125-130.

  107. Eguchi, S., Takatsuki, M., Hidaka, M., Soyama, A., Ichikawa, T., Kanematsu, T.. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. The American journal of surgery, vol.201, no.4, 498-502.

  108. Rifatbegovic Z, Mesic D, Ljuca F, Zildzic M, Avdagic M, Grbic K, Agic M, Hadziefendic B. Effect of probiotics on liver function after surgery resection for malignancy in the liver cirrhotic. Med Arh 2010;64:208-211. 

관련 콘텐츠

오픈액세스(OA) 유형

GOLD(Hybrid)

저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로